
lfchen@life.illinois.edu
517 Med. Sci. Bldg.
Office: (217) 333-7764
Lab: (217) 333-7864
Fax: (217) 244-5858
Mail to:
Department of Biochemistry
University of Illinois
600 S Mathews Ave
Urbana, IL 61801
Lin-Feng Chen
Assistant Professor of Biochemistry
Education
B.S. 1987 Xiamen University, China
M.S. 1990 Peking Union Medical University
Ph.D. 1999 Kyoto University, Japan
Postdoc. 1999-2003 Gladstone Institute of Immunology and Virology, University of California, San Francisco
Epigenetic regulation of NF-κB; the role of NF-κB in apoptosis and cancer; cross-talk between NF-κB and other signaling pathways.
The eukaryotic transcription factor NF-κB regulates a wide range of host genes that govern the inflammatory and immune responses in mammals. The NF-κB signaling pathway controls multiple key cellular processes, including programmed cell death, cell proliferation, and differentiation. NF-κB is activated by a variety of chemokines, bacteria, viruses and their products via distinct signal transduction pathways mediated by different receptors, including TNF-a receptors, Toll-like receptors, and antigen-specific T- and B-cell receptors.
The long-term goals of this laboratory are to determine how the NF-κB transcription factor complex is regulated at the molecular level and to elucidate the roles of NF-κB in inflammation, apoptosis, and tumorigenesis. In particular, we are interested in dissecting how different stimuli converge to activate NF-κB under normal and pathological conditions using a combination of biochemical, molecular, cellular, and genetic approaches.
Currently, we are interested in the role of post-transcriptional modifications of NF-κB and histones in the regulation of NF-κB signaling pathway.
- Post-translational modifications and NF-κB
activation
While it is clear that post-translational modifications, including phosphorylation and acetylation, play critical roles in shaping the nuclear function of NF-κB, many unanswered questions remain. For example, how do these modifications regulate NF-κB in vivo? Do they contribute significantly to the NF-κB's proinflammatory or anti-apoptotic functions? Is there a "transcription factor code" generated by acetylation, phosphorylation, and other modifications? If so, does it mediate the selection of specific target genes or control the strength and duration of the nuclear action of NF-κB? Answering these questions would advance our understanding of how NF-κB is regulated and could also provide exciting new therapeutic options for manipulating NF-κB action in cancer or inflammation. - Chromatin remodeling and NF-κB activation
To increase the accessibility of the cell’s transcription and replication machinery to promoters, chromatin remodeling must occur. For example, the conformation of chromatin is altered by chromatin remodeling complexes and the N-terminal tails of histones are modified by enzymes, including histone acetyltransferases and deacetylases, kinases, and methyl transferases. These enzymes play important roles in regulation of gene expression by modifying the histones and thus controlling the accessibility of chromatin by accessory regulator factors. Several of these enzymes interact with NF-κB and regulate NF-κB-dependent transactivation. However, it remains largely unknown whether and how chromatin remodeling mediates NF-κB target gene selection. How are these enzymes regulated in the NF-κB signaling pathway? Using different approaches including chromatin immunoprecipitation assays, we will identify the enzymes that are recruited to different NF-κB target genes in a stimulus-specific manner and determine how these recruitments are regulated.
Representative Publications
Lamb A, Yang XD, Tsang YH, Li JD, Higashi H, Hatakeyama M, Peek RM, Blanke SR, Chen LF. 2009. "Helicobacter pylori CagA activates NF-κB by inducing TRAF6-mediated K63-ubiquitination of TAK1." EMBO Report (in press)
Yang XD, Lamb A, Chen LF. 2009. "Methylation, a new epigenetic mark for protein stability." Epigenetics. (in press)
Yang XD, Huang B, Li MX, Lamb A, Kelleher NL, Chen LF. 2009. "Negative regulation of NF-κB action by Set9-mediated lysine methylation of RelA subunit." EMBO J. 28:1055-1066
Huang B, Yang XD, Zhou MM, Ozato K, Chen LF. 2009. "Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA." Mol. Cell. Biol. 29(5):1375-87
Kwon H., Brent M.M., Getachew R., Jayakumar P., Chen L.F., Schnoelzer M., McBurney M.W., Marmorstein R., Greene W.C., and Ott M. 2008. "Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T-cell hyperactivation." Cell Host and Microbe 3:158-67.
Murakami Y., Chen L.F., Sanechika N., Kohzaki H., Ito Y. 2007. "Transcription factor Runx1 recruits the polyomavirus replication origin to replication factories." J. Cell Biochem. 100(5):1313-23.
Williams S., Kwon H., Chen L.F., Greene W.C. 2007. "Sustained Induction of NF-κB Is required for efficient expression of latent HIV-1." J Virol. 81:6043-56.
Ishinaga H., Jono H., Lim J.H., Kweon S.M., Xu H., Ha U.H., Xu H., Koga T., Yan C., Feng X.H., Chen L.F.*, Li J.D.*. 2007. "TGF-Β induces p65 acetylation to enhance bacteria-induced NF-κB activation." EMBO J. 26:1150-1162 (*corresponding author).
Williams S., Chen L.F., Kwon H., Ruiz-Jarabo C.M., Greene W.C. 2006. NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139-149.
Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. 2005. SIRT1 Protects against Microglia-dependent Amyloid-Β Toxicity through Inhibiting NF-κB Signaling. J. Biol. Chem. 280: 40364-40374.
Chen L.F.*, Williams S., Mu Y., Nakano H., Duerr J.M., Buckbinder L., and Greene W.C.*. 2005. "RelA phosphorylation regulates RelA acetylation." Mol. Cell. Biol. 25:7966-7975 (*corresponding author)
Chen, L.-F. and Greene, W.C. (2005) "Assessing acetylation of NF-κB," Methods. 36:368-375.
Chen, L.-F. and Greene, W.C. (2004) "Shaping the nuclear action of NF-κB," Nat. Rev. Mol. Cell. Biol. 5:302–401. [Abstract]
Chen, L.-F. and Greene, W.C. (2003) "Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation," J. Mol. Med. 81: 549–557. [Abstract]
Chen, L.-F., Mu, Y., and Greene, W.C. (2002) "Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB," EMBO J. 21:6539–6548. [Abstract]
Chen, L.-F., Fischle, W., Verdin, E., and Greene, W.C. (2001) "Duration of nuclear NF-κB action regulated by reversible acetylation," Science 293:1653–1657. [Abstract]